DICP OpenIR
学科主题分析化学
LC-MS based metabolomics for disease biomarker discovery and confirmation
Xu GW(许国旺); Zhao XJ(赵欣捷); Yin PY(尹沛源); Huang Q(黄强); Zhou LN(周丽娜); Lu X(路鑫)
会议文集36th International Symposium on High Performance Liquid Phase Separations and Related Techniques
会议名称36th International Symposium on High Performance Liquid Phase Separations and Related Techniques
会议日期2011-6-19
2011
会议地点布达佩斯
页码1-0
出版者待补充
出版地待补充
合作性质特邀报告
部门归属1808
主办者Hungarian Society for Separation Sciences
英文摘要Complex diseases such as cancer, diabetes and obesity arise from an interaction of genetic and environmental factors. Their (early) diagnosis is very difficult, especially based on only singular biomarker. The move toward a biomarker group is a tendency, especially in the translational medicine applications. Metabolomics is a technique based on analyzing as many endogenetic metabolites as possible. It has shown a great potential in finding biomarker group. At this moment NMR and MS-based methods are used to analyze the metabolome, unfortunately, because of the complexity, until now no a single method can analyze the total metabolome. To resolve this problem, in our group an integrated platform has been developed, it mainly consists of one-dimensional and multi-dimensional GC-MS and LC-MS. RP-UHPLC and HILIC are online or off-line combined to separate hydrophilic and hydrophobic metabolites producing the complementary metabolite information. Applications of an ultra-high capacity small molecule chip (UHC-chip)-MS in the metabolomics are also explored. In the meantime, a comprehensive identification method of the metabolites was suggested. As the examples, we shall report our newest work on the metabolic biomarker discovery of ovarian cancer and prediabetes by using non-target metabolomics analysis to ‘fish’ the differential metabolites and target LC-MRM MS analysis to confirm the found biomarker group.; Complex diseases such as cancer, diabetes and obesity arise from an interaction of genetic and environmental factors. Their (early) diagnosis is very difficult, especially based on only singular biomarker. The move toward a biomarker group is a tendency, especially in the translational medicine applications. Metabolomics is a technique based on analyzing as many endogenetic metabolites as possible. It has shown a great potential in finding biomarker group. At this moment NMR and MS-based methods are used to analyze the metabolome, unfortunately, because of the complexity, until now no a single method can analyze the total metabolome. To resolve this problem, in our group an integrated platform has been developed, it mainly consists of one-dimensional and multi-dimensional GC-MS and LC-MS. RP-UHPLC and HILIC are online or off-line combined to separate hydrophilic and hydrophobic metabolites producing the complementary metabolite information. Applications of an ultra-high capacity small molecule chip (UHC-chip)-MS in the metabolomics are also explored. In the meantime, a comprehensive identification method of the metabolites was suggested. As the examples, we shall report our newest work on the metabolic biomarker discovery of ovarian cancer and prediabetes by using non-target metabolomics analysis to ‘fish’ the differential metabolites and target LC-MRM MS analysis to confirm the found biomarker group.
文献类型会议论文
条目标识符http://cas-ir.dicp.ac.cn/handle/321008/116053
专题中国科学院大连化学物理研究所
通讯作者Xu GW(许国旺)
推荐引用方式
GB/T 7714
Xu GW,Zhao XJ,Yin PY,et al. LC-MS based metabolomics for disease biomarker discovery and confirmation[C]. 待补充:待补充,2011:1-0.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[许国旺]的文章
[赵欣捷]的文章
[尹沛源]的文章
百度学术
百度学术中相似的文章
[许国旺]的文章
[赵欣捷]的文章
[尹沛源]的文章
必应学术
必应学术中相似的文章
[许国旺]的文章
[赵欣捷]的文章
[尹沛源]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。